84314-04-5

Basic information

• Product Name: 4-(4-chloro-3-nitrophenyl)-4-oxobutanoic acid
• Synonyms: 4-(4-chloro-3-nitrophenyl)-4-oxobutanoic acid
• CAS NO: 84314-04-5
• Molecular Weight: 257.63
• Mol File: 84314-04-5.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: 4-(4-chloro-3-nitrophenyl)-4-oxobutanoic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(4-chloro-3-nitrophenyl)-4-oxobutanoic acid(84314-04-5)
• EPA Substance Registry System: 4-(4-chloro-3-nitrophenyl)-4-oxobutanoic acid(84314-04-5)

Safety Data

• Hazardous Substances Data: 84314-04-5(Hazardous Substances Data)

Upstream product

• 3984-34-7 4-(4-chlorophenyl)-4-oxobutanoic acid 

Downstream Products

• 68415-20-3 6-(4-morpholin-4-yl-3-nitro-phenyl)-4,5-dihydro-2H-pyridazin-3-one 
• 84313-90-6 6-(3-amino-4-morpholino-phenyl)-4,5-dihydro-3(2H)-pyridazinone 
• 84314-03-4 2-(morpholin-4-yl)-5-(6-oxo-1,4,5,6-tetrahydropyridazin-3-yl)benzonitrile 
• 103604-63-3 5-(4-Ethyl-6-oxo-1,4,5,6-tetrahydro-pyridazin-3-yl)-2-morpholin-4-yl-benzonitrile 
• 84314-02-3 3-(3-cyano-4-morpholino-benzoyl)-propionic acid 
• 84313-97-3 6-(3-acetamido-4-morpholinophenyl)-4,5-dihydro-2H-pyridazine-3-one 
• 102625-20-7 2-Morpholin-4-yl-5-(5-oxo-tetrahydro-furan-3-carbonyl)-benzonitrile 
• 65854-68-4 3-(3-amino-4-morpholino-benzoyl)propionic acid 
• 1073119-35-3 butyl 4-(4-chloro-3-nitrophenyl)-4-oxobutanoate 
• 337515-72-7 4-[4-(methylamino)-3-nitrophenyl]-4-oxobutanoic acid 
• 90799-02-3 4-(3-amino-4-chloro-phenyl)-4-oxo-butyric acid 
• 141-82-2 malonic acid 
• 96-99-1 4-chloro-3-nitrobenzoate 
• 56872-65-2 3-(3-nitro-4-morpholino-benzoyl)-propionic acid 

Relevant articles and documents

2-PHENYL-INDOLES AS PROSTAGLANDIN D2 RECEPTOR ANTAGONISTS

The present invention is directed to 2-phenyl-indole compounds (A), their preparation, pharmaceutical compositions containing these compounds, and their pharmaceutical use in treating a patient suffering from a PGD2-mediated disorder including, but not li

2-PHENYL-INDOLES AS PROSTAGLANDIN D2 RECEPTOR ANTAGONISTS

The present invention is directed to a compound of Formula (XVI) wherein R, R2, R3, R4, R5, R6, R7 and n are as defined herein, or a pharmaceutically acceptable salt, hydrate, or solvate thereof, a pharmaceutically acceptable prodrug thereof, or a pharmac